Corrigendum to ‘A randomized controlled,dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody,in healthy Chinese adults’. [Int. Immunopharmacol. 75 (2019) 105807] |
| |
| Institution: | 1. Department of Pharmacy, Peking University People''s Hospital, Beijing, China;2. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China;3. United-Power Pharma Tech Co., Ltd., Beijing, China;4. Xuzhou Medical University, Xuzhou, China;5. Department of Rheumatology and Immunology, Peking University People''s Hospital, Beijing, China;6. Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;7. Aix-Marseille University, 27 bd Jean Moulin, 13385 Marseille Cedex 05, France;8. The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People''s Hospital, Qingyuan, China;9. Shenyang Sunshine Pharmaceutical Co., Ltd, Shenyang, China;10. State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China;11. National Engineering Research Center for Protein Drugs, Beijing, China |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
